145 related articles for article (PubMed ID: 15302768)
1. Similarities and differences in asthma and COPD. The Dutch hypothesis.
Bleecker ER
Chest; 2004 Aug; 126(2 Suppl):93S-95S; discussion 159S-161S. PubMed ID: 15302768
[No Abstract] [Full Text] [Related]
2. [Phenotype specific therapy of COPD].
Rothe T
Praxis (Bern 1994); 2014 Dec; 103(25):1509-14. PubMed ID: 25491053
[TBL] [Abstract][Full Text] [Related]
3. Asthma and COPD: differences and similarities. With special reference to the usefulness of budesonide/formoterol in a single inhaler (Symbicort) in both diseases.
Decramer M; Selroos O
Int J Clin Pract; 2005 Apr; 59(4):385-98. PubMed ID: 15853852
[TBL] [Abstract][Full Text] [Related]
4. Overlap syndrome of asthma and COPD predicts low quality of life.
Kauppi P; Kupiainen H; Lindqvist A; Tammilehto L; Kilpeläinen M; Kinnula VL; Haahtela T; Laitinen T
J Asthma; 2011 Apr; 48(3):279-85. PubMed ID: 21323613
[TBL] [Abstract][Full Text] [Related]
5. Early life origins of chronic obstructive pulmonary disease.
Svanes C; Sunyer J; Plana E; Dharmage S; Heinrich J; Jarvis D; de Marco R; Norbäck D; Raherison C; Villani S; Wjst M; Svanes K; Antó JM
Thorax; 2010 Jan; 65(1):14-20. PubMed ID: 19729360
[TBL] [Abstract][Full Text] [Related]
6. Physiologic similarities and differences between COPD and asthma.
Sciurba FC
Chest; 2004 Aug; 126(2 Suppl):117S-124S; discussion 159S-161S. PubMed ID: 15302772
[TBL] [Abstract][Full Text] [Related]
7. Smoking cessation effectiveness in smokers with COPD and asthma under real life conditions.
Gratziou Ch; Florou A; Ischaki E; Eleftheriou K; Sachlas A; Bersimis S; Zakynthinos S
Respir Med; 2014 Apr; 108(4):577-83. PubMed ID: 24560410
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 levels in the pathophysiology of chronic obstructive pulmonary disease and bronchial asthma.
Spiropoulos K; Trakada G; Nikolaou E; Prodromakis E; Efremidis G; Pouli A; Koniavitou A
Respir Med; 2003 Aug; 97(8):983-9. PubMed ID: 12924528
[TBL] [Abstract][Full Text] [Related]
9. [Differences and similarities in the evaluation and diagnostic workup].
Clarenbach CF; Kohler M
Ther Umsch; 2014 May; 71(5):262-6. PubMed ID: 24794335
[TBL] [Abstract][Full Text] [Related]
10. The association of exposure to hepatitis B and C viruses with lung function and respiratory disease: a population based study from the NHANES III database.
Goh LY; Card T; Fogarty AW; McKeever TM
Respir Med; 2014 Dec; 108(12):1733-40. PubMed ID: 25456709
[TBL] [Abstract][Full Text] [Related]
11. Day-to-day variability of oscillatory impedance and spirometry in asthma and COPD.
Timmins SC; Coatsworth N; Palnitkar G; Thamrin C; Farrow CE; Schoeffel RE; Berend N; Diba C; Salome CM; King GG
Respir Physiol Neurobiol; 2013 Jan; 185(2):416-24. PubMed ID: 22960661
[TBL] [Abstract][Full Text] [Related]
12. Is forced expiratory volume in six seconds a valid alternative to forced vital capacity?
Vandevoorde J; Swanney M
Eur Respir J; 2006 Dec; 28(6):1288-9; author reply 1289-90. PubMed ID: 17138690
[No Abstract] [Full Text] [Related]
13. How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1.
Barisione G; Crimi E; Bartolini S; Saporiti R; Copello F; Pellegrino R; Brusasco V
Eur Respir J; 2009 Jun; 33(6):1396-402. PubMed ID: 19196811
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status.
Miravitlles M; Soriano JB; Ancochea J; Muñoz L; Duran-Tauleria E; Sánchez G; Sobradillo V; García-Río F
Respir Med; 2013 Jul; 107(7):1053-60. PubMed ID: 23597591
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD).
Izquierdo-Alonso JL; Rodriguez-Gonzálezmoro JM; de Lucas-Ramos P; Unzueta I; Ribera X; Antón E; Martín A
Respir Med; 2013 May; 107(5):724-31. PubMed ID: 23419828
[TBL] [Abstract][Full Text] [Related]
16. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
[TBL] [Abstract][Full Text] [Related]
17. Lung function impairment, COPD hospitalisations and subsequent mortality.
Garcia-Aymerich J; Serra Pons I; Mannino DM; Maas AK; Miller DP; Davis KJ
Thorax; 2011 Jul; 66(7):585-90. PubMed ID: 21515553
[TBL] [Abstract][Full Text] [Related]
18. COPD exacerbations .1: Epidemiology.
Donaldson GC; Wedzicha JA
Thorax; 2006 Feb; 61(2):164-8. PubMed ID: 16443707
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
[TBL] [Abstract][Full Text] [Related]
20. Rationale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD.
Postma DS; Boezen HM
Chest; 2004 Aug; 126(2 Suppl):96S-104S; discussion 159S-161S. PubMed ID: 15302769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
